期刊文献+

重症手足口病免疫球蛋白治疗的机理探讨 被引量:42

Mechanism of intravenous immunoglobulin therapy for severe hand-foot-mouth disease:a review
原文传递
导出
摘要 手足口病是由多种肠道病毒感染导致的一种急性儿科传染病。近年来,我国肠道病毒71型(EV71)手足口病发病率急剧上升,重症病例时有报道,严重威胁儿童健康。临床上对于重症手足口病的治疗缺乏有效手段,主要以对症治疗和支持疗法为主。静脉注射人免疫球蛋白由健康献血员血浆提取纯化而来,含有包括EV71在内的多种肠道病毒的中和抗体,可作为重症手足口病被动免疫和免疫调节的重要手段,值得关注。 Hand-foot-mouth disease(HFMD) is an acute infectious disease caused by various enteroviruses.Recently,large HFMD outbreaks caused by enterovirus type 71(EV71) have been frequently reported in China,posing great threats on children’s health.There is no specific antiviral therapy for severe HFMD,and patient management mainly depends on supportive and symptomatic treatment.Intravenous immunoglobulin(IVIG) is a pharmaceutical preparation of human IgG that is pooled from thousands of healthy blood donors,and contained neutralization antibodies against various enteroviruses,including EV71.IVIG therapy should be carefully administrated for severe HFMD considering its role on passive immunization against EV71 and immune regulation.
出处 《生物工程学报》 CAS CSCD 北大核心 2011年第5期712-716,共5页 Chinese Journal of Biotechnology
基金 国家重大科技专项(Nos.2009ZX10004-204 2008ZX10004-015)资助~~
关键词 肠道病毒71型 手足口病 免疫球蛋白 中和抗体 enterovirus type 71 hand-foot-mouth disease(HFMD) intravenous immunoglobulin(IVIG) neutralization antibody
  • 相关文献

参考文献32

  • 1Yang F, Ren L, Xiong Z, et al. Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol, 2009, 47(7): 2351-2352.
  • 2Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol, 2010, 901): 1097-1105.
  • 3Wang SM, Liu CC. Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther, 2009, 7(6): 735-742.
  • 4Arnson Y, Shoenfeld Y, Amital H. Intravenous immunoglobulin therapy for autoimmune diseases. Autoimmunity, 2009, 42(6): 553-560.
  • 5Bayary J, Dasgupta S, Misra N, et al. Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms. Int Immunopharmacol, 2006, 6(4): 528-534.
  • 6Hemming VG. Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases. Clin Diagn Lab Immunol, 2001, 8(5): 859-863.
  • 7Mouthon L, Lortholary O. Intravenous immunoglobulins in infectious diseases: where do we stand? Clin Microbiol Infect, 2003, 9(5): 333-338.
  • 8Hemming VG, Prince GA, Groothuis JR, et al. Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. Clin Microbiol Rev, 1995, 8(1): 22-33.
  • 9Bayry J, Lacroix-Desmazes S, Kazatchkine MD, et al. Intravenous irnmunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era? Trends Pharmacol Sci, 2004, 25(6): 306-310.
  • 10Brunetti L, DeSantis ER. Treatment of viral myocarditis caused by coxsackievirus B. Am J Health Syst Pharm, 2008, 65(2): 132-137.

二级参考文献16

  • 1何登明,张建勇.手足口病患者心肌标志物检测的临床意义[J].实用医药杂志,2004,21(7):617-617. 被引量:7
  • 2李紫璞,米庆.手足口病的诊断与治疗[J].山东医药,2004,44(22):67-68. 被引量:45
  • 3杨智宏,朱启镕,李秀珠,王晓红,王建设,胡家瑜,唐伟,崔爱利.2002年上海儿童手足口病病例中肠道病毒71型和柯萨奇病毒A组16型的调查[J].中华儿科杂志,2005,43(9):648-652. 被引量:636
  • 4吴铁吉.病毒性心肌炎诊断标准(修订草案)[J].中华儿科杂志,2000,38(2):75-75.
  • 5Coiovic M, Dimitrijevic M, Sonnenburg C, et al. Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in aduit chronic ITP. Hematol J,2003,4 ( 5 ) : 358-362.
  • 6参照卫生部2008年5月6日公布的手足口病防治指南[M].
  • 7McMina PC.An overview of the evolution of enterovirus 71 andits clinical and public health significant[J].FEMS Microbiol Rev,2002,26(1):91-107.
  • 8Ho M.Enterovirus 71:The virus,its infections and outbreaks[J].J Microbio Immunol Infection,2002,33(4):205-216.
  • 9杨锡强.大剂量免疫球蛋白输注在儿科常见疾病中的应用.中国实用儿科杂志,2004,19(7):399-399.
  • 10胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.

共引文献98

同被引文献346

引证文献42

二级引证文献183

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部